baber/WOPTO huggingface dataset:
Patent AU-2010229675-A1 (AU)
Title: Methods and compositions for immunization against virus
Inventor: CHI-HUEY WONG
IPC: A61K39/21
Filed: 2010-03-26
Abstract: Immunogenic compositions comprising partially glycosylated viral glycoproteins for use as vaccines against viruses are provided. Vaccines formulated using mono-, di-, or tri-glycosylated viral surface glycoproteins and polypeptides provide potent and broad protection against viruses, even across strains. Pharmaceutical compositions comprising monoglycosylated hemagglutinin polypeptides and vaccines generated therefrom and methods of their use for prophylaxis or treatment of viral infections are disclosed. Methods and compositions are disclosed for influenza virus HA, NA and M2, RSV proteins F, G and SH, Dengue virus glycoproteins M or E, hepatitis C virus glycoprotein E1 or E2 and HIV glycoproteins gp120 and gp41.
Patent AU-2010239360-A1 (AU)
Title: Photoacoustic detection of analytes in solid tissue and detection system
Inventor: VIATOR JOHN A
IPC: G01N21/17
Filed: 2010-04-20
Abstract: A preferred system for detecting an analyte in solid tissue (12), such as an intact lymph node, in vitro includes a laser (22) arranged to generate a pulsed laser beam into solid tissue, which can be a fully intact lymph node. An acoustic sensor, and preferably at least three acoustic sensors (20a, 20b, 20c) are arranged in different positions to span a three dimensional space, such as in an X, Y and Z coordinate system, to detect photoacoustic signals generated within the lymph node. At least one computer (28) receives signals from the acoustic sensor(s). The computer determines the presence or absence of, and preferably the position of analyte, from the signals and the timing of the signals. A preferred method for detecting an analyte in a lymph node in vitro includes exposing an extracted lymph node to a pulsed laser beam. A photoacoustic signal is sensed. The photoacoustic signal is analyzed to confirm the presence or absence of an analyte in the lymph node. Preferably, multiple photoacoustic signals are sensed from sensors that span a three dimensional space and the position of analyte is also determined.
Patent AU-2010270596-A1 (AU)
Title: Stable crystalline polymorphs of the dipotassium salt of (S) -2- {4- [2- (2, 4-diamino-quinazolin-6-yl) -ethyl] -benzoylamino} -4-methylene-pentanedioic acid
Inventor: PIMPLASKAR HARISH K
IPC: A61P19/02
Filed: 2010-07-07
Abstract: The present invention provides stable crystalline polymorphic forms of antifolate compounds, particularly (5)-2-{4-[2-(2,4-diamino-quinazolin-6-yl)-ethyl]- benzoylamino}-4-methylene-pentanedioic acid, dipotassium salt, and methods of preparation thereof. The polymorphs may be in the form of hydrates. The invention further provides pharmaceutical compositions comprising the polymorphs and methods of treatment using the polymorphs. The polymorphs are useful in the treatment of multiple conditions, including abnormal cell proliferation, inflammatory diseases, asthma, and arthritis, and the polymorphs may be administered alone in or combination with on or more further active agents.
Patent AU-2010296299-A1 (AU)
Title: Chromene compound
Inventor: TAKAHASHI TOSHIAKI
IPC: C08F2/44
Filed: 2010-09-15
Abstract: Disclosed is a photochromic chromene compound which is a compound (formula (1)) having an indeno(2,1-f)naphtho(1,2-b)pyran structure as a basic skeleton, wherein the structure has an aryl group or heteroaryl group (R group) bonded to the 6-position carbon atom and has, bonded to the 7-position carbon atom, an electron-donating group (R group) having a Hammett number δp of -0.1 or smaller.
Patent AU-2010299464-A1 (AU)
Title: Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
Inventor: LI JUNZHONG
IPC: D06L4/70
Filed: 2010-09-21
Abstract: The present invention relates to novel sulfoperoxycarboxylic acid compounds, and methods for making and using them. The sulfoperoxycarboxylic compounds of the invention are storage stable, water soluble and have low to no odor. Further, the compounds of the present invention can be formed from non-petroleum based renewable materials. The compounds of the present invention can be used as antimicrobials, and bleaching agents. The compounds of the present invention are also suitable for use as coupling agents.
Patent AU-2010314602-A1 (AU)
Title: Use of danshensu, notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
Inventor: HAN JINGYAN
IPC: A61P3/06
Filed: 2010-11-04
Abstract: Use of danshensu, notoginsenoside R1 or their combination in the preparation of medicaments for preventing and treating diseases caused by microcirculation disorder.
Patent AU-2010321943-A1 (AU)
Title: Accordion bioreactor
Inventor: CUELLO JOEL L
IPC: C12N1/12
Filed: 2010-11-18
Abstract: Disclosed herein are bioreactors including a first sheet and a second sheet (one or both of which is substantially transparent to light), wherein the second sheet is disposed adjacent to the first sheet, and the first and second sheets are sealed along a first longitudinal edge, a second longitudinal edge, a first horizontal edge, a second horizontal edge, and at least one intermediate horizontal seal between the first horizontal edge and the second horizontal edge, thereby forming at least two chambers for holding fluid in series along a vertical axis, wherein each of the two or more chambers is oriented at an angle relative to the vertical axis, wherein the angle is about 0° to about 90° and at least one of the chambers is oriented at an angle greater than 0°, and wherein there is at least one opening in each of the first horizontal edge, the second horizontal edge, and intermediate horizontal seal(s); a support structure comprising at least one horizontal support, wherein the horizontal support is located at or near the position of the intermediate horizontal seal; a reservoir below the second horizontal edge of the first and second sheets; and a means for pumping fluid from the reservoir to the first horizontal edge of the first and second sheets. Also disclosed are methods of culturing cells including circulating a suspension of cells in a disclosed bioreactor. In some examples, the cells include microalgae, macroalgae, bacteria, fungi, insect cells, plant cells, animal cells (such as mammalian cells), or plant or animals tissue or organs. In particular examples, the method includes exposing the culture in the bioreactor to a light source (such as sunlight or an artificial light source).
Patent AU-2010332051-A1 (AU)
Title: Passive solids supply system and method for supplying solids
Inventor: BIELENBERG JAMES R
IPC: F23K1/00
Filed: 2010-12-14
Abstract: A solids supply system having a solids deaeration zone and a solids pump zone, and a method for supplying the solids e.g., pulverized dry coal, to an application, e.g., gasification process. The solids deaeration zone includes a container having a passageway defined by one or more sloped walls. The solids deaeration zone is operable to deaerate and convey the solids to the solids pump zone. In the solids deaeration zone, the solids become sufficiently compacted prior to and upon entry into the solids pump zone to be effectively conveyed through the solids pump zone.
Patent AU-2010333749-A1 (AU)
Title: Herpes simplex virus vaccines
Inventor: YAO FENG
IPC: A61K39/245
Filed: 2010-12-20
Abstract: The present invention is directed to Herpes simplex-2 viruses that may be used in vaccines to immunize patients against genital herpes.
Patent AU-2010350863-A1 (AU)
Title: Method and apparatus for detecting a magnetic characteristic variable in a core
Inventor: HAMBERGER PETER
IPC: H01F27/38
Filed: 2010-04-14
Abstract: Method for detecting a magnetic characteristic variable, in particular the magnetic field strength (H1), in a section (L1) of a core (2) through which a magnetic flux flows, wherein part (18) of the magnetic flux is branched off from the core (2) and is guided, at least in sections, in a magnetic shunt part (7), wherein the magnetic material of the shunt part (7) is not saturated, and wherein the magnetic characteristic variable (H1) is determined from this part (18) of the magnetic flux that has been branched off or from a variable derived therefrom using a sensor and evaluation device (8, 10).
Patent WO-2012024720-A1 (WO)
Inventor: MASTROYANIS PERRY
IPC: A47G19/12
Filed: 2011-08-22
Abstract: L'invention concerne un pot à usages multiples doté d'un indicateur de température, le pot étant formé d'un matériau ayant une conductivité thermique élevée. Le pot selon l'invention comporte un thermomètre à cristaux liquides fixé sur un côté du pot. Le thermomètre est agencé de manière à indiquer des températures de liquide à l'intérieur du pot allant de 35 degrés Celsius à plus de 65 degrés Celsius. Le thermomètre à cristaux liquides se présente sous la forme d'une étiquette collée au côté extérieur du pot et est scellé à l'aide d'une couche de résine recouvrant l'étiquette.
Patent AU-2011200857-A1 (AU)
Title: Method and system for adding translation in a videoconference
Inventor: DOVEV LIBERMAN
IPC: G10L15/00
Filed: 2011-02-28
Abstract: A multilingual multipoint videoconferencing system provides real-time translation of speech by conferees. Audio streams containing speech may be 5 converted into text and inserted as subtitles into video streams. Speech may also be translated from one language to another, with the translated speech inserted into video streams as and choose the subtitles or replacing the original audio stream with speech in the other language generated by a text to speech engine. Different conferees may receive different translations of the 10 same speech based on information provided by the conferees on desired languages. MULTI-LINGUAL-TRANSLATE D-VIDEO-CONFERENCE (MLTV-MCU) 234 CONTROL 220 MODUE 236 230 [ 226 CONTROL 210 1 AUDI0 22 CONTROL NI254 239 MULTIMEDIA COMMUNICATION 246 INPUT MODULES 249 MENU VIDEO OUTPUT 248 (MG) !MODULES 244 -/ -245 250 MEDIA LINE FIG. 2 (AUDIO, VIDEO) CONTROL LINE CONVERTED TEXT
Patent AU-2011203800-A1 (AU)
Title: Dietary regimens useful for mimicking caloric restriction
Inventor: PRIDMORE-MERTEN SYLVIE
IPC: A23L33/20
Filed: 2011-01-05
Abstract: The invention provides dietary regimens useful mimicking caloric restriction in animals. The regimens use a first diet containing one or more dietary supplements suitable for mimicking caloric restriction when the animal is a young animal; a second diet containing one or more dietary supplements suitable for mimicking caloric restriction when the animal is an adult animal; and a third diet containing one or more dietary supplements suitable for mimicking caloric restriction when the animal is a senior animal; wherein the dietary supplements in the first diet, second diet, and third diet are not all be the same dietary supplements.
Patent AU-2011218613-A1 (AU)
Title: Video interaction
Inventor: DALE HERIGSTAD
IPC: H04N7/173
Filed: 2011-08-26
Abstract: A method comprising while primary video content is being presented through a first communication channel on a primary video device, on a handheld wireless device, displaying 5 information describing video content available for viewing on the primary video device, the information received through a second communication channel; and in response to user input, displaying and storing a graphical element representing the information. bN
Patent AU-2011219764-A1 (AU)
Title: Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
Inventor: HECKEL ARMIN
IPC: A61K31/381
Filed: 2011-02-25
Abstract: The present invention relates to novel thienopyhmidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
Patent AU-2011221601-A1 (AU)
Title: Urethanes, ureas, amidines and related inhibitors of factor Xa
Inventor: TOVBIN DMITRY GENNADIEVICH
IPC: A61K31/16
Filed: 2011-03-02
Abstract: The invention relates to a new class of compounds, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions that are effective as selective inhibitors of factor Xa, both in the isolated state and in a complex with other proteins. The compounds of the invention can be used for treating and preventing diseases, such as acute coronary syndrome, myocardial infarction, unstable angina, refractory angina, thromboses caused by post-thrombolytic therapy or coronary angioplasty, acute ischemia mediated cerebrovascular syndrome, embolic stroke, thrombotic stroke, and other diseases in humans and other mammals associated with blood coagulation problems.
Patent AU-2011226960-A1 (AU)
Title: Systems and methods for providing share assessment data with cash flow analysis
IPC: G06Q30/00
Filed: 2011-09-29
Abstract: A computer-implemented method for transforming company performance data thereby to provide cash flow assessment data, the method including: maintaining access to a repository of data for a plurality of shares, wherein the data includes, for each share, company performance data for the company in respect of which the share is issued; receiving, from a client, a cash flow assessment request for a given one of the shares; obtaining from the repository, for the user-selected share, values for a set of data fields associated with the given one of the shares, wherein values include, for one or more historical periods, a profit quantifier, a paid dividend quantifier, and one or more cash flow quantifiers; determining a funding gap/surplus quantifier for each historical period wherein each funding gap quantifier is derived from a calculation that accepts inputs including the paid dividends quantifier and one or more of the cash flow quantifiers; defining data indicative of a chart to be displayed by the client, wherein the chart displays, for each historical period, overlaid on common axes, the profit quantifier, the paid dividends quantifier, one or more of the cash flow quantifiers, and the funding gap quantifier; and providing the defined data to the client thereby to allow generation of the chart. Figure 4A
Patent AU-2011228838-A1 (AU)
Title: Apparatus for generating power from fluid flow
Inventor: ROBERTS PETER
IPC: F03B13/08
Filed: 2011-03-16
Abstract: An apparatus for generating electricity using water flow in a body of water comprises: an array of spaced apart elements. Each element defines an elongate flow passage and has an upstream side and an elgonate downstream side, each element being provided with a series of holes spaced along its length and the downstream side extending and tapering away in the direction of flow. The elements are arranged side by side such that opposing walls of adjacent elements define a venturi section and a first diffuser section extending downstream from the venturi section. The apparatus also comprises: - a flow conduit having an inlet and an outlet; - a turbine located in the flow conduit; and - a generator connected to the turbine; The flow passages are connected to the outlet of the flow conduit such that the flow of water through the venturi sections causes water to be drawn through the flow conduit out via the holes the resulting flow driving the turbine.
Patent AU-2011232505-A1 (AU)
Title: Double sealing labyrinth chamber for use with a downhole electrical submersible pump
Inventor: MERRILL DAN
IPC: E21B43/12
Filed: 2011-03-23
Abstract: A labyrinth seal assembly for an electrical submersible pumping system that communicates downhole pressure to a pump motor while sealing wellbore fluids from the motor. The labyrinth seal assembly includes a chamber circumscribing a pump shaft, labyrinth tubes, upper and lower shaft seals, and inner and outer guide tubes coaxially circumscribing the shaft. One labyrinth tube has an end in fluid communication with the wellbore fluid and another has an end in fluid communication with the pump motor. The labyrinth tubes extend into the chamber from opposite directions and each have an opening distal from where they enter the chamber. A port is provided in the inner guide tube distal from the upper shaft seal, and a port in the outer guide tube is provided proximate the upper shaft seal. Thus a labyrinth path is provided between the upper shaft seal and the chamber.
Patent AU-2011236049-A1 (AU)
Title: Sequence-specific inhibition of small RNA function
Inventor: ZAMORE PHILLIP D
IPC: A01N43/04
Filed: 2011-10-14
Abstract: The present invention relates to the discovery of a method for inhibiting RNA silencing in a target sequence-specific manner. RNA silencing requires a set of conserved cellular factors to suppress expression of gene-encoded polypeptide. The invention provides compositions for sequence-specific inactivation of the RISC component of the RNA silencing pathway, and methods of use thereof. The RISC inactivators of the present invention enable a variety of methods for identifying and characterising miRNAs and siRNAs, RISC-associated factors, and agents capable of modulating RNA silencing. Therapeutic methods and compositions incorporating RISC inactivators and therapeutic agents identified through use of RISC inactivators are also featured.
Patent AU-2011239223-A1 (AU)
Title: Side mounted air seeder product container
Inventor: CRESSWELL MARK
IPC: A01C7/20
Filed: 2011-10-20
Abstract: An air seeder cart apparatus has a primary container assembly with a plurality of primary product containers, with primary fill hatches at tops thereof An air distribution network comprises product conduits and primary metering devices that dispense agricultural products from each primary product container into one of the product conduits. A secondary product container is mounted on a side of the primary container assembly and has a secondary fill hatch much lower than the primary fill hatches, and a secondary metering mechanism dispenses product from the secondary product container into one of the product conduits. The secondary product container is convenient for receiving bagged agricultural products from a low truck bed. Unopened product bags may be stored on a grate inside the secondary product container so they will be available if required. Weighing of product in the container can be provided. 17 15 3 n 13 47 23 21 H' 6 25 25B 21 6
Patent AU-2011246851-A1 (AU)
Title: Methods, compositions and kits for providing a therapeutic treatment
Inventor: ASHUR-FABIAN OSNAT
IPC: A01N37/12
Filed: 2011-04-28
Abstract: The present invention encompasses a therapeutic method which employs treatment of a disease such as cancer with triiodothyronine (T3) together with an anti-thyroid treatment such as treatment with an anti-thyroid agent, treatment with radioiodine and surgical removal of all or part of the thyroid gland. A pharmaceutical composition comprising T3 and an anti-thyroid agent and a kit comprising the same are also encompassed by the invention.
Patent AU-2011247826-A1 (AU)
Title: Inelastic strap based exercise apparatus
Inventor: DALEBOUT WILLIAM
IPC: A63B21/068
Filed: 2011-11-07
Abstract: Docket Number 10-005.11.01 An inelastic exercise apparatus includes an elongated member having a pair of ends. The elongated member is an inelastic strap. The apparatus also includes an anchor having a first portion for mounting to a structure and a second coupling portion. The exercise apparatus further includes a rigid yoke including a yoke housing having a first end and a second end, wherein the first end of the yoke housing is coupled to the second coupling portion of the anchor and the second end of the yoke housing defines a translation channel configured to receive the elongated member. 100 120 126 116 170a 170b
Patent AU-2011251411-A1 (AU)
Title: Operation control apparatus of air-conditioning apparatus and air-conditioning apparatus comprising same
Inventor: KIBO KOUSUKE
IPC: F24F11/76
Filed: 2011-04-22
Abstract: The disclosed control device (80) for an air-conditioning device improves the operating efficiency of the air-conditioning device, thereby saving energy. Said air-conditioning device (10) has indoor units (40, 50, 60), which contain use-side heat exchangers (42, 52, 62), and an outdoor unit (20). The air-conditioning device performs indoor temperature control in which devices provided in the indoor units are controlled such that the indoor temperature approaches a set temperature. The air-conditioning device is provided with requested-temperature computation units (47b, 57b, 67b) that compute requested evaporation temperatures or requested condensation temperatures on the basis of either: a current use-side heat-exchanger heat exchange amount and a larger use-side heat-exchanger heat exchange amount; or an operating level that results in the current use-side heat-exchanger heat exchange amount and an operating level that results in a larger use-side heat-exchanger heat exchange amount.
Patent AU-2011259756-A1 (AU)
Title: Method for culturing adipocytes
Inventor: LACASA DANIELE
IPC: C12N5/077
Filed: 2011-05-23
Abstract: The present invention relates to a method for culturing adipocytes, in which a homogeneous population of mature adipocytes isolated from adipose tissue is cultured on a three-dimensional culture substrate.
Patent AU-2011260318-A1 (AU)
Title: Antipsychotic injectable depot composition
Inventor: GUTIERRO ADURIZ IBON
IPC: A61K47/34
Filed: 2011-05-31
Abstract: The present invention is directed to a composition that can be used to deliver an antipsychotic drug such as risperidone as an injectable in-situ forming biodegradable implant for extended release providing therapeutic plasma levels from the first day. The composition is in the form of drug suspension on a biodegradable and biocompatible copolymer or copolymers solution using water miscible solvents that is administered in liquid form. Once the composition contacts the body fluids, the polymer matrix hardens retaining the drug, forming a solid or semisolid implant that releases the drug in a continuous manner. Therapeutic plasma levels of the drug can be achieved since the first day up to at least 14 days or more.
Patent AU-2011265423-A1 (AU)
Title: System and method for deactivating IP sessions of lower priority
Inventor: WIRTANEN JEFF
IPC: H04L12/24
Filed: 2011-12-21
Abstract: SYSTEM AND METHOD FOR DEACTIVATING IP SESSIONS OF LOWER 5 Systems and Methods are provided for deactivating IP sessions of lower priority. There may be instances when a mobile device (10) moves from a first area (30) supporting a plurality of IP sessions to a second area (40) supporting fewer IP sessions. In this situation, if the mobile device (10) has more IP sessions than is supported by the second area (40), then the wireless network will deactivate IP sessions. According to an 1o embodiment of the application, the mobile device (10) determines a respective priority for each of the IP sessions and transmits an indication of each respective priority to the wireless network. According to another embodiment of the application, the wireless network deactivates IP sessions that are indicated to be of lower priority. Accordingly, IP sessions that are not deactivated are those indicated by the mobile device (10) to be of s greater priority.